IP Library › Granted Patent US 10,543,218
Granted Patent B2
US 10,543,218 · App. 15/573,362 · Granted Jan 28, 2020

Human papilloma virus replication inhibitors

Inventors: Mart Ustav, Sr. (Õssu, EE); Ene Ustav (Õssu, EE); Andres Männik (Õssu, EE); Mart Toots (Õssu, EE); Andres Tover (Õssu, EE)
Assignee: Icosagen Cell Factory OÜ
A61K31/566A61K31/341A61K31/4184A61K31/496A61K31/517A61K31/52A61K31/568A61K31/58A61P31/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,543,218
App. No.
15/573,362
Granted
Jan 28, 2020
Kind
B2
Abstract

Novel antiviral compounds for inhibiting one or more phases of HPV replication cycle are disclosed. Moreover, a mechanism for the inhibition is suggested and targets for further antiviral compounds are disclosed.

Claims (1)

1. An antiviral compound selected from the group consisting of

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2019
From: USTAV, MART, SR.; USTAV, ENE; MÄNNIK, ANDRES; TOOTS, MART; TOVER, ANDRES
To: ICOSAGEN CELL FACTORY OÜ
Reel/Frame 049707/0269 →
Continuity (2)
Provisional Application 62159572 · May 11, 2015
Related Publication 20180133228A1 · May 17, 2018